Related Experiment Videos
[Uterine sarcoma. Apropos of 25 cases]
O Bennani1, A Himmi, M Laghzaoui
1Service de Gynécologie-Obstétrique, CHU Ibn Rochd, Casablanca, Maroc.
Revue Francaise De Gynecologie Et D'Obstetrique
|January 1, 1995
Summary
Uterine body sarcoma is a rare, aggressive cancer with a poor prognosis, often diagnosed during surgery. Early detection and appropriate treatment are crucial for improving patient outcomes in this challenging gynecologic malignancy.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Context:
- Analysis of 25 uterine body sarcoma cases over 15 years (1977-1992) at a Moroccan teaching hospital.
- Uterine sarcomas are rare (0.9% of uterine cancers), postmenopausal, and have a poor prognosis.
Purpose:
- To analyze the clinical characteristics, diagnosis, treatment, and survival rates of uterine body sarcoma.
- To highlight the severity and diagnostic challenges of uterine sarcomas.
Summary:
- Metrorrhagia was the most common symptom; diagnosis was often post-surgical.
- Leiomyosarcoma was the predominant histological type.
- Treatment involved surgery (hysterectomy with/without appendectomy), radiotherapy, or chemotherapy, with low survival rates (10% at 2 years, 5% at 5 years).
Impact:
- Identified age, histology, tumor extent, and treatment as prognostic factors.
- Emphasizes the need to recognize uterine sarcoma's severity despite advancements in other gynecologic treatments.